NCT02627248View on ClinicalTrials.gov

Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Breast Cancer
Interventions
DRUG

Huaier Granule

20g tid, orally

DRUG

Epirubicin

70 mg/m² ivdrip, d1 for both TEC and ET regimes

DRUG

Docetaxel

75 mg/m² ivdrip, d2 for both TEC and ET regimes

DRUG

Cyclophosphamide

600 mg/m² ivdrip, d2 for TEC regimes

Trial Locations (1)

250012

RECRUITING

Qilu hospital of Shandong University, Ji'nan

All Listed Sponsors
lead

Shandong University

OTHER